Found: 13
Select item for more details and to access through your institution.
Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.
- Published in:
- Pharmacogenomics Journal, 2014, v. 14, n. 5, p. 424, doi. 10.1038/tpj.2014.16
- By:
- Publication type:
- Article
Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up[sup *].
- Published in:
- Internal Medicine Journal, 2003, v. 33, n. 9/10, p. 427, doi. 10.1046/j.1445-5994.2003.00456.x
- By:
- Publication type:
- Article
Goserelin toxicities and preferences for ovarian suppression method in pre-menopausal women with breast cancer.
- Published in:
- Internal Medicine Journal, 2016, v. 46, n. 10, p. 1153, doi. 10.1111/imj.13169
- By:
- Publication type:
- Article
Pregnancy screening prior to chemotherapy administration.
- Published in:
- Internal Medicine Journal, 2016, v. 46, n. 10, p. 1222, doi. 10.1111/imj.13214
- By:
- Publication type:
- Article
Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer.
- Published in:
- Internal Medicine Journal, 2015, v. 45, n. 2, p. 218, doi. 10.1111/imj.12658
- By:
- Publication type:
- Article
Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 1, p. 121, doi. 10.1007/s00520-013-1941-1
- By:
- Publication type:
- Article
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 12, p. 1888, doi. 10.1038/bjc.2015.173
- By:
- Publication type:
- Article
The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 6, p. 1122, doi. 10.1038/bjc.2014.404
- By:
- Publication type:
- Article
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer.
- Published in:
- British Journal of Cancer, 2014, v. 110, n. 3, p. 648, doi. 10.1038/bjc.2013.753
- By:
- Publication type:
- Article
Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 5, p. 1338, doi. 10.1038/bjc.2013.388
- By:
- Publication type:
- Article
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 8, p. 1269, doi. 10.1038/s41416-024-02604-y
- By:
- Publication type:
- Article
Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study.
- Published in:
- British Journal of Cancer, 2006, v. 95, n. 10, p. 1309, doi. 10.1038/sj.bjc.6603440
- By:
- Publication type:
- Article